EMERALD Trial课件 EMERALDTrial EnhancedMyocardialEfficacyandRemovalbyAspirationofLiberatedDebris EMERALDTrial 505patientspresentingwithinsixhoursofchestpainonsetwith≥2mmSTelevationorleftbundlebranchblockandplanneduseofprimaryorrescuePCI Randomized,open-label,multicenter GuardWireDistalProtection 0.028”GuardWirePlusSystem...
参考文献：[1]Kudo M, et al. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 2020 Aug;69(8):1492-1501.[2]Kudo M, et al. IMbrave150: Efficacy and Safety...
4. Jia Fan, et al. EMERALD-2 Trial Design ILCA 2020. 5. Jia Fan, et al. EMERALD-3 Trial Design ESMO 2022. 6.Ghassan K, et al. NEJM Evid 2022;1(8). 7.中国临床肿瘤学会(CSCO).原发性肝癌诊疗指南.人民卫...
2.Wang K, Xiang Y J, Yu H M, et al. Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial[J]. Nature Medicine, 2024: 1-8. 3.M. Kudo , R. Lencioni ...
Purpose/Objective(s) The EMERALD trial evaluated the feasibility and safety of ultra-hypofractionation with MRgSABR in pancreatic cancer. We present the dosimetric impact of adaptive MRgSABR. Materials/Methods A single-center three-arm phase 1 non-randomized safety study (ISRCTN10557832). Patients ...
EP: 6.The EMERALD Trial: Elacestrant in Patients with HR+, HER2- Advanced Breast Cancer EP: 7.The TROPION-Breast01 Trial: Datopotamab Deruxtecan in HR+, HER2- Breast Cancer EP: 8.Approaches to Treatment Decision-Making and Sequencing for HR+, HER2- Metastatic Breast Cancer EP:...
The EMERALD trial (NCT03778931), a multicenter, international, randomized, open-label, controlled phase 3 trial evaluated elacestrant as a monotherapy versus SoC for the treatment of ER+/HER2- advanced or mBC. The trial enrolled patients who had received 1...
Dryland farming systems trial results In field trials at Emerald, Queensland, in 1993-99, various rotations of cotton with sorghum, wheat or fallow, were compared. The cotton was sown early or ... Nilantha Hulugalle,ken Rohde,Don Yule - 《Australian Cottongrower》 被引量: 1发表: 1999年 ...
Results of a randomized phase II trial of 2nd-line treatment for advanced soft tissue sarcoma comparing trabectedin,eribulin and pazopanib:Japan Clinical Oncology Group study JCOG1802(2ND-STEP) 比较曲贝替定、艾立布林、帕唑帕尼用于晚期软组织肉瘤二线治疗的II期随机研究结果:日本临床肿瘤学组研究JCOG1802(...
We bring fresh perspectives, local expertise, and creative solutions to solve complex challenges. The diversity of our global teams translates into diverse problem‑solving, better trial design, and stronger participant engagement—that’s how we deliver excellence....